Indoco Remedies Limited

INDOCO.NS·NSE
Compare
231.50−5.00 (−2.11%)today
At close: Oct 21, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close236.50
Open236.50
Day range228.10238.10
52-week range162.19291.00
Off day high−2.77%
Off 52-week high−20.45%
Volume87.43K
Avg. volume (3M)1.09M
Market cap21.34B
EPS (TTM)0.3200
Forward P/E19.05
P/E ratio (TTM)723.44
Dividend yield0.08% (0.2000)
Beta (5Y)—
Shares outstanding92.17M
Short interest—
Earnings dateJul 21, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
INDOCO.NS IOLCP.NS IPCALAB.BO INDSWFTLAB.BO BAJAJHCARE.NS AARTIDRUGS.BO
Market cap 21.34B 52.40B 486.30B 30.65B 10.96B 35.59B
P/E (TTM) 723.4 31.2 37.1 51.9 44.5 18.6
Forward P/E 19.1 17.2 27.2 — — 14.0
Price/book 2.1 2.9 6.0 2.1 2.0 2.3
Dividend yield 0.08% 0.55% 0.33% — 0.44% 0.50%
1-year change −17.82% +92.46% +42.82% +243.47% −25.89% −21.36%
Today −2.11% −2.52% +5.60% −1.56% −3.86% −2.29%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

What visitors to INDOCO.NS's page also look at.

Company Mkt cap Price Today
FDC LIMITEDFDC.NS — 338.85 −1.34%
IPCA LABORATORIES LTDIPCALAB.NS 461.26B 1,818.10 +0.20%
SHILPA MEDICARE LTDSHILPAMED.NS 165.31B 845.20 −3.54%
HIKAL LIMITEDHIKAL.NS 25.99B 210.76 −2.99%
ERIS LIFESCIENCES LIMITEDERIS.NS 156.52B 1,128.20 +0.70%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All INDOCO.NS news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.